Clinical outcome of SARS-CoV-2 disease in relation to the humoral response in fully vaccinated solid organ transplant (SOT) recipients
Latest Information Update: 04 Feb 2022
At a glance
- Drugs Elasomeran (Primary) ; Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Therapeutic Use
Most Recent Events
- 04 Feb 2022 New trial record
- 31 Dec 2021 Results published in the Transplantation Proceedings